Ayvakit
Chemical Name | avapritinib |
Dosage Form | Tablet (oral; 100 mg, 200 mg, 300 mg) |
Drug Class | Kinase inhibitors |
System | Digestive |
Company | Blueprint Medicines |
Approval Year | 2020 |
Indication
- Ayvakit is indicated for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.